Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1988-1-12
|
pubmed:abstractText |
Hepatocellular carcinoma is often an aggressive tumour and, if unresectable, carries a poor prognosis, especially in the presence of jaundice. We report on a jaundiced patient with an unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin (Adriamycin). The initial response of the patient has been encouraging. This form of therapy deserves further evaluation in patients with unresectable hepatocellular carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0256-9574
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
701-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2825364-Adult,
pubmed-meshheading:2825364-Carcinoma, Hepatocellular,
pubmed-meshheading:2825364-Doxorubicin,
pubmed-meshheading:2825364-Humans,
pubmed-meshheading:2825364-Infusions, Intra-Arterial,
pubmed-meshheading:2825364-Iodized Oil,
pubmed-meshheading:2825364-Liver Neoplasms,
pubmed-meshheading:2825364-Male
|
pubmed:year |
1987
|
pubmed:articleTitle |
Unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin. A case report.
|
pubmed:affiliation |
Department of Surgery, University of Cape Town.
|
pubmed:publicationType |
Journal Article,
Case Reports
|